Key terms

About TFX

Teleflex, Inc. provides medical technology products which enable healthcare providers to improve patient outcomes and enhance patient and provider safety. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest TFX news

Feb 26 12:01am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Exact Sciences (EXAS), Teleflex (TFX) and Amgen (AMGN) Feb 23 7:20am ET Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Insulet (PODD) and Teleflex (TFX) Feb 23 7:20am ET RBC Capital Reaffirms Their Buy Rating on Teleflex (TFX) Feb 23 5:57am ET Teleflex Inc.: A Balanced Outlook with Caution Advised – Hold Rating Justified Feb 23 5:35am ET Teleflex Hold Rating Justified Amidst Modest Growth and Multiple Headwinds Feb 23 5:30am ET Analysts’ Top Healthcare Picks: Bausch Health Companies (BHC), Teleflex (TFX) Feb 23 12:20am ET Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Teleflex (TFX) and Madrigal Pharmaceuticals (MDGL) Feb 22 7:13am ET Teleflex Inc to Discuss Quarterly and Annual Financial Results Feb 22 6:33am ET Teleflex sees 2024 adjusted EPS $13.55-$13.95, consensus $13.84 Feb 22 6:31am ET Teleflex reports Q4 adjusted EPS $3.38, consensus $3.26 Jan 22 12:10pm ET Analysts Conflicted on These Healthcare Names: Abbott Labs (ABT), Adagene (ADAG) and Teleflex (TFX) Jan 12 7:25am ET Teleflex price target raised to $272 from $228 at RBC Capital Dec 22 7:58am ET Teleflex price target raised to $270 from $221 at Truist Dec 13 7:56am ET Wells Fargo Reaffirms Their Hold Rating on Teleflex (TFX) Dec 11 4:32pm ET These 2 MedTech Stocks Look Too Cheap to Ignore, Says Morgan Stanley Dec 05 6:31am ET Teleflex awarded peripheral access agreement with Premier Dec 04 6:32am ET Teleflex upgraded to Overweight at Morgan Stanley on Palette upside, strong core Dec 04 6:23am ET Teleflex upgraded to Overweight from Equal Weight at Morgan Stanley

No recent news articles are available for TFX

No recent press releases are available for TFX

TFX Financials

1-year income & revenue

Key terms

TFX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TFX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms